Prelude Therapeutics (PRLD) Stock Chart & Stock Price History $0.86 -0.02 (-2.45%) As of 04/24/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Prelude Therapeutics Stock Price Performance 5 Day Performance+6.37%1 Month Performance+23.90%3 Month Performance-29.09%6 Month Performance-43.32%Year-To-Date Performance-32.42%1 Year Performance-78.67% Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address PRLD Stock Chart for Friday, April, 25, 2025 PRLD Chart by TradingView Prelude Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2025$0.88$0.86-2.45%$0.89$0.83114,977 shs$48.64 million04/23/2025$0.94$0.88-5.91%$0.95$0.8599,145 shs$49.86 million04/22/2025$0.80$0.94+17.53%$0.94$0.82179,962 shs$52.99 million04/21/2025$0.81$0.80-1.40%$0.85$0.7876,846 shs$45.09 million04/18/2025$0.81$0.81$0.86$0.75205,948 shs$44.68 million04/17/2025$0.77$0.81+5.19%$0.86$0.75205,948 shs$44.68 million04/16/2025$0.75$0.77+2.35%$0.80$0.72160,868 shs$42.47 million04/15/2025$0.69$0.75+8.40%$0.77$0.69133,621 shs$41.49 million04/14/2025$0.71$0.69-2.01%$0.72$0.66166,479 shs$38.28 million04/11/2025$0.64$0.71+10.35%$0.71$0.64190,863 shs$39.06 million Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/10/2025$0.66$0.64-3.45%$0.68$0.63147,619 shs$35.40 million04/09/2025$0.61$0.66+8.88%$0.69$0.61163,290 shs$36.66 million04/09/2025$0.61$0.66+8.88%$0.69$0.61163,290 shs$36.66 million04/08/2025$0.65$0.61-5.80%$0.69$0.61197,204 shs$33.67 million04/08/2025$0.65$0.61-5.80%$0.69$0.61197,204 shs$33.67 million04/07/2025$0.68$0.65-3.99%$0.72$0.61281,323 shs$35.75 million04/04/2025$0.71$0.68-4.67%$0.71$0.66186,390 shs$37.23 million04/03/2025$0.79$0.71-10.05%$0.76$0.71154,610 shs$39.06 million04/02/2025$0.77$0.79+2.19%$0.80$0.74218,162 shs$43.42 million04/01/2025$0.77$0.77+0.04%$0.87$0.76262,175 shs$42.49 million03/31/2025$0.80$0.77-3.71%$0.87$0.751.03 million shs$42.47 million03/28/2025$0.68$0.80+17.29%$0.84$0.74878,306 shs$44.11 million03/27/2025$0.64$0.68+6.61%$0.68$0.63286,920 shs$37.61 million03/26/2025$0.70$0.64-8.04%$0.71$0.63347,362 shs$35.27 million03/25/2025$0.72$0.70-3.42%$0.76$0.68137,222 shs$38.36 million03/24/2025$0.71$0.72+1.32%$0.75$0.7274,430 shs$39.71 million Related Companies Neurogene Stock Price Chart Genfit Stock Price Chart Eledon Pharmaceuticals Stock Price Chart Voyager Therapeutics Stock Price Chart Tevogen Bio Stock Price Chart Kodiak Sciences Stock Price Chart Canopy Growth Stock Price Chart Esperion Therapeutics Stock Price Chart INmune Bio Stock Price Chart Inhibrx Stock Price Chart Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRLD) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
